(Q46286203)

21 December 2017

title

Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients (English)

1 reference

21 December 2017

invasive fungal infections

0 references

1 reference

1 reference

4

John R Perfect

1 reference

21 December 2017

author name string

Joseph Menzin

1

1 reference

21 December 2017

Juliana L Meyers

2

1 reference

21 December 2017

Mark Friedman

3

1 reference

21 December 2017

Amelia A Langston

5

1 reference

21 December 2017

Robert P Danna

6

1 reference

21 December 2017

George Papadopoulos

7

1 reference

21 December 2017

publication date

1 October 2009

1 reference

21 December 2017

American Journal of Health-System Pharmacy

published in

1 reference

21 December 2017

volume

66

1 reference

21 December 2017

issue

19

1 reference

21 December 2017

page(s)

1711-1717

1 reference

21 December 2017

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Risk factors for Candida species colonization of neonatal intensive care unit patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Epidemiology of infections in the adult medical intensive care unit of a cancer hospital.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

The direct cost and incidence of systemic fungal infections

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Epidemiology of candidiasis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Excess mortality, length of stay, and costs associated with serious fungal infections among elderly cancer patients: findings from linked SEER-Medicare data

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Burden of aspergillosis-related hospitalizations in the United States.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Trends in Infectious Disease Hospitalizations in the United States, 1980-1994

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Aspergillosis and other systemic mycoses. The growing problem

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis .

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Recent advances in antifungal chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

Treatment options for invasive fungal infections

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080325

31 March 2020

Identifiers

DOI

10.2146/AJHP080325

1 reference

21 December 2017

PubMed ID

19767376

1 reference

21 December 2017